AIMC Topic: Ligands

Clear Filters Showing 251 to 260 of 660 articles

SCORCH: Improving structure-based virtual screening with machine learning classifiers, data augmentation, and uncertainty estimation.

Journal of advanced research
INTRODUCTION: The discovery of a new drug is a costly and lengthy endeavour. The computational prediction of which small molecules can bind to a protein target can accelerate this process if the predictions are fast and accurate enough. Recent machin...

Prediction of protein mononucleotide binding sites using AlphaFold2 and machine learning.

Computational biology and chemistry
In this study, we developed a system that predicts the binding sites of proteins for five mononucleotides (AMP, ADP, ATP, GDP, and GTP). The system comprises two machine learning (ML)-based predictors using a convolutional neural network and a gradie...

DeepBindBC: A practical deep learning method for identifying native-like protein-ligand complexes in virtual screening.

Methods (San Diego, Calif.)
Identifying native-like protein-ligand complexes (PLCs) from an abundance of docking decoys is critical for large-scale virtual drug screening in early-stage drug discovery lead searching efforts. Providing reliable prediction is still a challenge fo...

Protein-Ligand Docking in the Machine-Learning Era.

Molecules (Basel, Switzerland)
Molecular docking plays a significant role in early-stage drug discovery, from structure-based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive power is critically dependent on the protein-ligand scoring function....

Informed Chemical Classification of Organophosphorus Compounds via Unsupervised Machine Learning of X-ray Absorption Spectroscopy and X-ray Emission Spectroscopy.

The journal of physical chemistry. A
We analyze an ensemble of organophosphorus compounds to form an unbiased characterization of the information encoded in their X-ray absorption near-edge structure (XANES) and valence-to-core X-ray emission spectra (VtC-XES). Data-driven emergence of ...

Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Molecular diversity
CNS disorders are indications with a very high unmet medical needs, relatively smaller number of available drugs, and a subpar satisfaction level among patients and caregiver. Discovery of CNS drugs is extremely expensive affair with its own unique c...

Molecule Design Using Molecular Generative Models Constrained by Ligand-Protein Interactions.

Journal of chemical information and modeling
In recent years, molecular deep generative models have attracted much attention for its application in drug design. The data-driven molecular deep generative model approximates the high dimensional distribution of the chemical space through learning...

AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.

European journal of medicinal chemistry
Artificial intelligence (AI) has been recognized as a powerful technique that can accelerate drug discovery during the hit compound identification step. However, most simple deep learning models have been used for naive pre-filtering as the predictio...

A Physics-Guided Neural Network for Predicting Protein-Ligand Binding Free Energy: From Host-Guest Systems to the PDBbind Database.

Biomolecules
Calculation of protein-ligand binding affinity is a cornerstone of drug discovery. Classic implicit solvent models, which have been widely used to accomplish this task, lack accuracy compared to experimental references. Emerging data-driven models, o...

Predicting Protein-Ligand Docking Structure with Graph Neural Network.

Journal of chemical information and modeling
Modern day drug discovery is extremely expensive and time consuming. Although computational approaches help accelerate and decrease the cost of drug discovery, existing computational software packages for docking-based drug discovery suffer from both...